MX2021003090A - Sal de erbumina de treprostinil. - Google Patents
Sal de erbumina de treprostinil.Info
- Publication number
- MX2021003090A MX2021003090A MX2021003090A MX2021003090A MX2021003090A MX 2021003090 A MX2021003090 A MX 2021003090A MX 2021003090 A MX2021003090 A MX 2021003090A MX 2021003090 A MX2021003090 A MX 2021003090A MX 2021003090 A MX2021003090 A MX 2021003090A
- Authority
- MX
- Mexico
- Prior art keywords
- treprostinil
- erbumine salt
- salt
- erbumine
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Crystallography & Structural Chemistry (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862732799P | 2018-09-18 | 2018-09-18 | |
| PCT/US2019/050632 WO2020060823A1 (en) | 2018-09-18 | 2019-09-11 | Erbumine salt of treprostinil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021003090A true MX2021003090A (es) | 2021-05-12 |
Family
ID=68052002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021003090A MX2021003090A (es) | 2018-09-18 | 2019-09-11 | Sal de erbumina de treprostinil. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220047535A1 (zh) |
| EP (1) | EP3853200B1 (zh) |
| JP (1) | JP7194817B2 (zh) |
| KR (1) | KR102659451B1 (zh) |
| CN (1) | CN112739679B (zh) |
| AU (1) | AU2019344541B2 (zh) |
| BR (1) | BR112021002200B1 (zh) |
| CA (1) | CA3112986C (zh) |
| EA (1) | EA202190552A1 (zh) |
| IL (1) | IL280891A (zh) |
| MX (1) | MX2021003090A (zh) |
| WO (1) | WO2020060823A1 (zh) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102697790A (zh) * | 2003-05-22 | 2012-10-03 | 联合治疗公司 | 化合物和释放前列环素类似物的方法 |
| CN1917866B (zh) | 2003-12-16 | 2010-12-15 | 联合治疗公司 | 曲前列环素或它的衍生物，或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途 |
| CN1917883B (zh) | 2003-12-16 | 2011-05-11 | 联合治疗公司 | 曲前列环素在制备改善肾功能的药物中的用途 |
| CN101287457B (zh) | 2004-04-12 | 2011-11-16 | 联合治疗公司 | Treprostinil用于治疗神经性糖尿病的足部溃疡的用途 |
| WO2008098196A1 (en) | 2007-02-09 | 2008-08-14 | United Therapeutics Corporation | Treprostinil treatment for interstitial lung disease and asthma |
| FR2920772B1 (fr) | 2007-09-11 | 2009-10-23 | Servier Lab | Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine |
| EP3002274A1 (en) | 2008-05-08 | 2016-04-06 | United Therapeutics Corporation | Treprostinil monohydrate |
| CA2726599C (en) | 2010-12-30 | 2017-07-25 | Alphora Research Inc. | Process for treprostinil salt preparation |
| EP3878452B1 (en) | 2013-01-09 | 2023-09-20 | United Therapeutics Corporation | Treatment of vasculopathy with prostacyclin and mesenchymal stem cells |
| JP2016516693A (ja) | 2013-03-15 | 2016-06-09 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルの塩 |
| AU2014349000B2 (en) | 2013-11-13 | 2019-01-17 | Cayman Chemical Company Incorporated | Amine salts of a prostacyclin analog |
| JO3624B1 (ar) | 2014-05-08 | 2020-08-27 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
| US20160243064A1 (en) * | 2015-02-21 | 2016-08-25 | Gavis Pharmaceuticals | Novel oral pharmaceutical compositions of treprostinil |
| JO3749B1 (ar) * | 2015-08-27 | 2021-01-31 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
| JP2020500882A (ja) * | 2016-12-05 | 2020-01-16 | コルセア ファーマ インコーポレイテッド | トレプロスチニルおよびその塩の皮膚投与および経皮投与方法 |
-
2019
- 2019-09-11 EP EP19773695.2A patent/EP3853200B1/en active Active
- 2019-09-11 KR KR1020217007704A patent/KR102659451B1/ko active IP Right Grant
- 2019-09-11 EA EA202190552A patent/EA202190552A1/ru unknown
- 2019-09-11 BR BR112021002200-7A patent/BR112021002200B1/pt active IP Right Grant
- 2019-09-11 US US17/274,883 patent/US20220047535A1/en active Pending
- 2019-09-11 WO PCT/US2019/050632 patent/WO2020060823A1/en active Application Filing
- 2019-09-11 CA CA3112986A patent/CA3112986C/en active Active
- 2019-09-11 CN CN201980060738.8A patent/CN112739679B/zh active Active
- 2019-09-11 MX MX2021003090A patent/MX2021003090A/es unknown
- 2019-09-11 AU AU2019344541A patent/AU2019344541B2/en active Active
- 2019-09-11 JP JP2021515022A patent/JP7194817B2/ja active Active
-
2021
- 2021-02-15 IL IL280891A patent/IL280891A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102659451B1 (ko) | 2024-04-23 |
| CN112739679B (zh) | 2024-03-12 |
| AU2019344541A1 (en) | 2021-03-18 |
| US20220047535A1 (en) | 2022-02-17 |
| EA202190552A1 (ru) | 2021-06-18 |
| WO2020060823A1 (en) | 2020-03-26 |
| BR112021002200B1 (pt) | 2024-03-12 |
| EP3853200A1 (en) | 2021-07-28 |
| AU2019344541B2 (en) | 2022-01-06 |
| JP2022500468A (ja) | 2022-01-04 |
| CN112739679A (zh) | 2021-04-30 |
| BR112021002200A2 (pt) | 2021-05-04 |
| CA3112986A1 (en) | 2020-03-26 |
| JP7194817B2 (ja) | 2022-12-22 |
| KR20210046028A (ko) | 2021-04-27 |
| EP3853200B1 (en) | 2024-01-24 |
| IL280891A (en) | 2021-04-29 |
| CA3112986C (en) | 2024-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022016566A (es) | Composiciones que comprenden una caseina y metodos para producir las mismas. | |
| MX2020010951A (es) | Anticuerpos anti-hla-g y utilizacion de los mismos. | |
| IN2014CH00247A (zh) | ||
| EP3847816A4 (en) | SIMPLIFICATIONS OF A LINEAR INTER-COMPONENT MODEL | |
| EP3703743A4 (en) | ORAL IMMUNOTHERAPY PROCEDURES | |
| JO3644B1 (ar) | تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به | |
| PH12020550871A1 (en) | Process for the preparation of opicapone and intermediates thereof | |
| CR20210158A (es) | Formas de dosificación pediátricas de vitamina d, métodos de elaboración y uso | |
| MX2017007259A (es) | Composiciones de sales metalicas. | |
| JOP20190163B1 (ar) | منشط nrf2 | |
| EP3890750A4 (en) | CARBORANE COMPOUNDS, CARBORANE ANALOGUES AND METHODS OF USE THEREOF | |
| EP3353149A4 (en) | PROCESS FOR THE PREPARATION OF INDOLIN COMPOUNDS AND A NOVEL INDOLIN SALT | |
| MX2019010640A (es) | Formas cristalinas de acido obeticolico. | |
| MX2021003090A (es) | Sal de erbumina de treprostinil. | |
| MX2015015746A (es) | Proceso para la preparacion de arformoterol o sal del mismo. | |
| WO2018075598A8 (en) | SYNTHESIS OF EZH2 INHIBITORS | |
| PH12017501869A1 (en) | (s)-2'-vinyl-abscisic acid derivatives | |
| MX2017000318A (es) | Derivados del acido abscisico sustituido en 3'. | |
| MX2017002609A (es) | Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso. | |
| NZ765226A (en) | Crystal form of urat1 inhibitor, and preparation method therefor | |
| WO2018229796A3 (en) | PROCESS FOR THE PREPARATION OF BETRIXABAN CHLORHYDRATE AND BETRIXABAN MALEATE SALT | |
| EP3752181A4 (en) | LEISHMANIASIS IMMUNOTHERAPY | |
| EP3709989A4 (en) | METHOD OF ADMINISTRATION OF TOLPERISON | |
| MX2019014989A (es) | Proceso para la preparacion de (s,s)-secoisolariciresinol diglucosido y (r,r)-secoisolariciresinol diglucosido. | |
| MX2021015198A (es) | Peptidos toxicos activados artificialmente. |